Hepatocellular adenoma and focal nodular hyperplasia: Value of gadoxetic acid-enhanced MR imaging in differential diagnosis

Radiology

Volumn 262, Issue 2, 2012, Pages 520-529

  Grazioli, Luigi ^a   Bondioni, Maria Pia ^a   Haradome, Hiroki ^b,d   Motosugi, Utaroh ^b   Tinti, Rita ^a   Frittoli, Barbara ^a   Gambarini, Sebastiana ^a   Donato, Francesco ^a   Colagrande, Stefano ^c  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF YAMANASHI   (Japan)

^c UNIVERSITY OF FLORENCE   (Italy)

^d KYORIN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GADOXETIC ACID;

ADULT; AGED; ARTICLE; CHILD; CLINICAL EFFECTIVENESS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; FATTY LIVER; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; LIVER ADENOMA; LIVER FOCAL NODULAR HYPERPLASIA; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

ADENOMA, LIVER CELL; ADOLESCENT; ADULT; AGED; CHILD; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOCAL NODULAR HYPERPLASIA; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; LIVER NEOPLASMS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84857421338     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.11101742     Document Type: Article

References (23)

1. Wanless IR, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985;5(6): 1194-1200. (Pubitemid 16222291)
2. Rooks JB, Ory HW, Ishak KG, et al. Epidemiology of hepatocellular adenoma: the role of oral contraceptive use. JAMA 1979;242(7): 644-648. (Pubitemid 9252465)
3. Cherqui D, Rahmouni A, Charlotte F, et al. Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations . Hepatology 1995;22(6):1674-1681.
4. Shortell CK, Schwartz SI. Hepatic adenoma and focal nodular hyperplasia. Surg Gynecol Obstet 1991;173(5):426-431.
5. Ichikawa T, Federle MP, Grazioli L, Nalesnik M. Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. Radiology 2000;214(3):861-868. (Pubitemid 30115393)
6. Semelka RC, Martin DR, Balci C, Lance T. Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement . J Magn Reson Imaging 2001;13(3): 397-401. (Pubitemid 32173407)
7. De Carlis L, Pirotta V, Rondinara GF, et al. Hepatic adenoma and focal nodular hyperplasia: diagnosis and criteria for treatment. Liver Transpl Surg 1997;3(2):160-165. (Pubitemid 27114028)
8. Lewin M, Handra-Luca A, Arrivé L, et al. Liver adenomatosis: classification of MR imaging features and comparison with pathologic findings. Radiology 2006;241(2): 433-440. (Pubitemid 44632889)
9. Laumonier H, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C, Trillaud H. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 2008;48(3):808-818.
10. Bioulac-Sage P, Balabaud C, Wanless IR. Diagnosis of focal nodular hyperplasia: not so easy. Am J Surg Pathol 2001;25(10): 1322-1325. (Pubitemid 32917128)
11. Vogl TJ, Kümmel S, Hammerstingl R, et al. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 1996;200(1):59-67. (Pubitemid 26197732)
12. Bartolozzi C, Crocetti L, Lencioni R, Cioni D, Della Pina C, Campani D. Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media. Eur Radiol 2007;17(10):2519-2530.
13. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2000;284(23):3043-3045.
14. Haradome H, Grazioli L, Tsunoo M, et al. Can MR fluoroscopic triggering technique and slow rate injection provide appropriate arterial phase images with reducing artifacts on gadoxetic acid-DTPA (Gd-EOB-DTPA)- enhanced hepatic MR imaging? J Magn Reson Imaging 2010;32(2):334-340.
15. Bioulac-Sage P, Blanc JF, Rebouissou S, Balabaud C, Zucman-Rossi J. Genotype phenotype classification of hepatocellular adenoma . World J Gastroenterol 2007;13(19): 2649-2654. (Pubitemid 46958719)
16. Silva AC, Evans JM, McCullough AE, Jatoi MA, Vargas HE, Hara AK. MR imaging of hypervascular liver masses: a review of current techniques. RadioGraphics 2009; 29(2):385-402.
17. Hussain SM, van den Bos IC, Dwarkasing RS, Kuiper JW, den Hollander J. Hepatocellular adenoma: findings at state-of-the-art magnetic resonance imaging, ultrasound, computed tomography and pathologic analysis. Eur Radiol 2006;16(9):1873-1886. (Pubitemid 44193172)
18. Filippone A, Blakeborough A, Breuer J, et al. Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine. J Magn Reson Imaging 2010;31(2):356-364.
19. Eisenberg LB, Warshauer DM, Woosley JT, Cance WG, Bunzendahl H, Semelka RC. CT and MRI of hepatic focal nodular hyperplasia with peripheral steatosis. J Comput Assist Tomogr 1995;19(3):498-500.
20. Giovanoli O, Heim M, Terracciano L, Bongartz G, Ledermann HP. MRI of hepatic adenomatosis: initial observations with gadoxetic acid contrast agent in three patients. AJR Am J Roentgenol 2008;190(5):W290-W293. (Pubitemid 351684910)
21. Halavaara J, Breuer J, Ayuso C, et al. Liver tumor characterization: comparison between liver-specific gadoxetic acid disodiumenhanced MRI and biphasic CT: a multicenter trial. J Comput Assist Tomogr 2006; 30(3):345-354. (Pubitemid 43922248)
22. Huppertz A, Balzer T, Blakeborough A, et al. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 2004;230(1): 266-275. (Pubitemid 37549812)
23. Rebouissou S, Bioulac-Sage P, Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol 2008;48(1):163-170. (Pubitemid 350199576)